To the full analysis
LeMaitre Vascular stock: growth
LMATLeMaitre Vascular reported $249.6M in revenue for fiscal 2025, up 13.5% on the prior year, up 14% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
11%
per year from 2006 to 2025, per share 6.2%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 14.0% | 12.3% | 11.0% |
| Revenue per share | 11.5% | 9.6% | 6.2% |
| Earnings | 22.2% | 22.2% | no data |
| Earnings per share | 19.4% | 19.2% | no data |
| Free cash flow | 18.5% | 23.3% | no data |
| Free cash flow per share | 15.9% | 20.4% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $34.63M | −$1.17M | −$1.5M |
| 2007 | $41.45M | −$2.93M | −$3.22M |
| 2008 | $48.72M | −$3.31M | −$157K |
| 2009 | $50.91M | $1.6M | $3.82M |
| 2010 | $56.06M | $6.01M | $4.49M |
| 2011 | $57.69M | $2.14M | $1.09M |
| 2012 | $56.74M | $2.57M | $3.4M |
| 2013 | $64.55M | $3.2M | $2.49M |
| 2014 | $71.1M | $3.92M | $4.32M |
| 2015 | $78.35M | $7.76M | $9.15M |
| 2016 | $89.15M | $10.59M | $14.05M |
| 2017 | $100.87M | $17.18M | $16.45M |
| 2018 | $105.57M | $22.94M | $16.45M |
| 2019 | $117.23M | $17.93M | $10.42M |
| 2020 | $129.37M | $21.22M | $31.82M |
| 2021 | $154.42M | $26.91M | $30.22M |
| 2022 | $161.65M | $20.64M | $22.15M |
| 2023 | $193.48M | $30.11M | $29.49M |
| 2024 | $219.86M | $44.04M | $37.16M |
| 2025 | $249.6M | $57.73M | $74.47M |
Revenue by region
Where LeMaitre Vascular, Inc. generates its revenue.
- Americas64%
- EMEA29%
- Asia Pacific7%
Figures as a table
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Americas | $63.65M | $69.36M | $81.47M | $102.27M | $109.44M | $130.31M | $144.58M | $159.67M | 64% |
| EMEA | $35.32M | $39.48M | $39.19M | $42.13M | $41.85M | $51.1M | $59.97M | $73.12M | 29.3% |
| Asia Pacific | $6.6M | $8.39M | $8.7M | $10.03M | $10.36M | $12.08M | $15.31M | $16.82M | 6.7% |
| Total revenue | $105.57M | $117.23M | $129.37M | $154.42M | $161.65M | $193.48M | $219.86M | $249.6M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.